JANX
#2352
Janux Therapeutics, Inc. - Common Stock
18.8 9 USD
+0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.68%
Changement Mensuel
+23.95%
Evolution sur 6 mois
+44.75%
Changement Annuel
-16.75%
Clôture Précédente
18.2 2
Open
18.8 9
Low
18.8 9
High
18.8 9
Volume
76
Financials
- Market Capitalization 1.15 B
- Employee 113
- Founded 2017
- CEO N/A
- Website www.januxrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKH11
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.37
ratio cours/chiffre d'affaires
40.01
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2310 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 14.31 USD | +2.65% | -0.90% | -14.00% | +26.64% | 1.22 B USD | ||
| 2324 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.27 USD | +1.64% | -1.92% | +8.35% | +151.68% | 1.20 B USD | ||
| 2362 |  KURA Kura Oncology, Inc. - Common Stock | 12.89 USD | +1.90% | -5.15% | +42.90% | +62.34% | 1.15 B USD | ||
| 2363 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.83 USD | -1.03% | -5.90% | +21.97% | +34.86% | 1.15 B USD |